1. EDITORIAL POLICIES — The publisher (PHARMAKON-Press) follows the guidelines of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. Upon submitting a manuscript to Epitheorese Klinikes Farmakologias kai Farmakokinetikes, all authors must be in agreement regarding its content and must ensure that the manuscript conforms to all applicable editorial policies outlined in this webpage.
1.1. Prerequisites for the Publication of Studies on Humans — Studies on humans must adhere to international and national regulations, and be in agreement with the Declaration of Helsinki or any other relevant set of ethical principles. All manuscripts aiming to be published as case reports should be prepared based on the 2013 CARE Checklist. The CONSORT 2010 Statement should be followed in the case of research report manuscripts describing parallel group randomised trials, and the STROBE Statement should be followed in the case of research report manuscripts describing cohort, case-control, or cross-sectional studies. In all cases, a clear declaration of the obtaining of informed consent by all human subjects / patients studied should be provided.
1.2. Prerequisites for the Publication of Studies on Animals — All manuscript aiming to be published as research reports and communicating the results of studies conducted on animals, should be written in accordance with the ARRIVE Guidelines 2.0.
1.3. Data Availability — Manuscript authors are encouraged to familiarize themselves with the FAIR principles, regarding the findability (F), accessibility (A), interoperability (I), and reuse (R) of digital assets, and to adhere to them, if applicable. To this end, manuscript authors should provide a statement outlining where the data generated during the respective study may be found. If public datasets are included in the manuscript’s study, the authors must include the following information in a subsection under the “Methodology” section of the manuscript entitled “Availability of data and materials”: the accession numbers of the datasets, the names of the repositories in which they can be found, and direct URLs for these datasets. Authors who are unable to share their data must disclose this and justify why their data are unavailable. Suitable repositories can be found at the Registry of Research Data Repositories.
1.4. Declarations — Upon submission of any manuscript to the journal, the corresponding author is required to declare: (i) that the manuscript has been prepared based on the journal’s guidelines and templates, that the authors’ details are accurate and their ORCIDs up-to-date, and that all data and claims presented in the manuscript are – to the best of his / her knowledge and belief – accurate and truthful, (ii) that he / she has secured the consent of all of his / her co-authors in acting as a corresponding author, as well as their approval for submitting the manuscript, in its current form, to the journal Epitheorese Klinikes Farmakologias kai Farmakokinetikes, (iii) that he / she understands that the unacknowledged use of generative artificial intelligence (AI) and AI-assisted technologies in the writing process of the manuscript is against the journal’s policy, and could lead to its rejection or the retraction of its published version, (iv) that the manuscript has not been published – in part or in full – before, nor is submitted for publication elsewhere, and (v) that the manuscript will not be submitted for publication elsewhere until the editorial process is complete. Upon acceptance of any manuscript for publication in this journal, the corresponding author is required to confirm the aforementioned declarations through a signed manuscript acceptance form; the latter must also be signed by all authors, and secures their consent for the manuscript to be published in the journal in its final form.
1.5. Acknowledgments — This is a mandatory section for all article types. In this section, authors should provide a clearly-written description or expression of gratitude for any help and / or funding received from individuals and / or institutions.
1.6. Conflict of Interest Statement — This is a mandatory section for all article types. All possible conflicts of interest should be declared by all authors in this section. Failure to do so could result in the rejection of the manuscript or the retraction of the published article affected. If no conflicts of interest exist, the authors are required to simply write “None to declare.” in this section.
1.7. Peer Review Confidentiality — The publisher and the journal’s staff treat all manuscripts submitted to the Epitheorese Klinikes Farmakologias kai Farmakokinetikes in confidence and in accordance with COPE’s Ethical Guidelines for Peer Reviewers. Reviewers are required to respect the confidentiality of the peer review process and to not reveal any details of a manuscript or of its peer review to anyone, either during or after the conclusion of the peer review process.
1.8. Misconduct — Data falsification, duplicate publication, plagiarism, image manipulation, unjustified changes in authorship, or a breach of confidentiality of the peer review process; all constitute misconduct. When misconduct by authors or reviewers is suspected, the publisher takes action and launches a preliminary investigation based on the guidance dictated by the flowcharts of COPE and the ICMJE guidelines. If the involved parties fail to respond to the publisher in a satisfactory manner, then an appropriate authority is asked to further investigate the misconduct. In cases where a misconduct is proven beyond all reasonable doubt, the published article is retracted. Otherwise, the publisher undertakes reasonable attempts to obtain a resolution and to correct the record, or archives the misconduct investigation as necessary.
1.9. Appeals and Complaints — Appeals and complaints regarding the decisions of the editor-in-chief can be addressed to the publisher via email and should be justified. The publisher will examine such appeals and complaints confidentially, but might seek the opinion of a number of members of the journal’s editorial board regarding any wrongdoing or omission identified in the said decisions before allowing for a re-review of the involved manuscripts.
2. OPEN ACCESS AND COPYRIGHT POLICIES—Epitheorese Klinikes Farmakologias kai Farmakokinetikes is an open-access journal that publishes articles distributed under the terms and conditions of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, thereby permitting the use, distribution, and reproduction in any medium provided the original work is properly cited. The copyright is retained by the author(s) under the terms and conditions of the aforementioned license.
3. PRIVACY POLICY — The publisher is the exclusive administrator of this website and is responsible for the processing of the personal data you submit, in accordance with the applicable General Data Protection Regulation (GDPR) EU 2016/679.
4. INDEXING— Articles published inEpitheorese Klinikes Farmakologias kai Farmakokinetikes are indexed, abstracted, and/or deposited in: Bibliovigilance, Chemical Abstracts, Crossref, EMBASE, Google Scholar, Potrico, Scilit, SCImago Journal & Country Rank, Scopus, and Sherpa Romeo.
5. REVENUE SOURCES, ADVERTISING, AND DIRECT MARKETING — The publisher’ revenue sources related to the publication of this journal are the article processing charge paid by the authors of the manuscripts accepted for publication and a limited number of subscriptions for the printed issues of the title. The publisher does not receive any institutional or organisational funding or support. The publisher does not receive any revenue from any sort of advertisement, whether online or in print. All direct marketing activities related to this journal are conducted by the publisher in the most appropriate, well-targeted, and unobstructed manner, with an accurate representation of the journal’s metrics, indexing, and scope.